Skip to main content
Signal8

Jenkins John Kenneth

SEC insider (Form 3/4/5 filer). CIK 0001742557. Director at Corbus Pharmaceuticals Holdings, Inc. (CRBP). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in NORWOOD, MA.

Companies Jenkins John Kenneth has filed insider reports for

  • Corbus Pharmaceuticals Holdings, Inc. (CRBP): Director
Jenkins John Kenneth profile photo

Jenkins John Kenneth

CIK: 0001742557

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Corbus Pharmaceuticals Holdings, Inc. logo
CRBP

Corbus Pharmaceuticals Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Jun 10, 2026
    Sale
    Direct
    4.8K shares at avg. $7.91$38K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    May 19, 2026
    Award
    Direct
    3.8K shares-
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    May 30, 2025
    Sale
    Direct
    2.8K shares at avg. $7.35$20K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    May 30, 2025
    Award
    Direct
    4.8K shares-

1-4 of 4